Dylan Hartley
Chief Scientific Officer · OnKure Therapeutics, Inc.
Individual
- 2024
- Aug 11, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Dylan Hartley files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jason A. Leverone - $3K in OKUR purchases and sales in the last 12 months
- Nicholas A. Saccomano - $994 in OKUR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dylan Hartley?
Dylan Hartley is a corporate insider, tracked as Chief Scientific Officer of OnKure Therapeutics, Inc. (OKUR). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Dylan Hartley submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.